(Q51498856)

5 April 2018

title

Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population. (English)

1 reference

5 April 2018

1 reference

1 reference

3

Bernard Zinman

1 reference

5 April 2018

Anthony J Hanley

6

object named as

Anthony J G Hanley

1 reference

5 April 2018

author name string

Juan Liu

1

1 reference

5 April 2018

T Kue Young

2

1 reference

5 April 2018

Stewart B Harris

4

1 reference

5 April 2018

Philip W Connelly

5

1 reference

5 April 2018

publication date

1 March 2006

1 reference

5 April 2018

published in

Obesity

1 reference

5 April 2018

volume

14

1 reference

5 April 2018

issue

3

1 reference

5 April 2018

page(s)

500-508

1 reference

5 April 2018

Insulin resistance syndrome, body mass index and the risk of ischemic heart disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Development of the multiple metabolic syndrome: an epidemiologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Lifestyle behaviors associated with lower risk of having the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Cardiovascular morbidity and mortality associated with the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Banting lecture 1988. Role of insulin resistance in human disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Weight gain and the risk of developing insulin resistance syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Association of the metabolic syndrome with both vigorous and moderate physical activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Decreased plasma adiponectin concentrations in women with dyslipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Adiponectin and development of type 2 diabetes in the Pima Indian population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

The metabolic syndrome: prevalence in worldwide populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Physical activity, physical fitness, and insulin and glucose concentrations in an isolated Native Canadian population experiencing rapid lifestyle change

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Specific patterns of food consumption and preparation are associated with diabetes and obesity in a Native Canadian community

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

The prevalence of NIDDM and associated risk factors in native Canadians.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Adiponectin in a native Canadian population experiencing rapid epidemiological transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

A simple, valid step test for estimating maximal oxygen uptake in epidemiologic studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Adiponectin and Metabolic Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Obesity, adiponectin and vascular inflammatory disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.65

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.65

1 reference

5 April 2018

1 reference

5 April 2018